List of Tables
Table 1. Global Human Insulin Injections Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Human Insulin Injections Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Human Insulin Injections Market Competitive Situation by Manufacturers in 2025
Table 4. Global Human Insulin Injections Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Human Insulin Injections Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Human Insulin Injections Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Human Insulin Injections Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Human Insulin Injections Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Human Insulin Injections, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Human Insulin Injections, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Human Insulin Injections, Product Types and Applications
Table 12. Global Key Manufacturers of Human Insulin Injections, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Insulin Injections Companies by Tier (Tier 1, Tier 2, Tier 3), based on Human Insulin Injections Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Insulin Injections Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Human Insulin Injections Sales by Region (K Dose), 2021–2026
Table 18. Global Human Insulin Injections Sales Market Share by Region (2021–2026)
Table 19. Global Human Insulin Injections Sales by Region (K Dose), 2027–2032
Table 20. Global Human Insulin Injections Sales Market Share by Region (2027–2032)
Table 21. Global Human Insulin Injections Revenue by Region (US$ Million), 2021–2026
Table 22. Global Human Insulin Injections Revenue Market Share by Region (2021–2026)
Table 23. Global Human Insulin Injections Revenue by Region (US$ Million), 2027–2032
Table 24. Global Human Insulin Injections Revenue Market Share by Region (2027–2032)
Table 25. North America Human Insulin Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Human Insulin Injections Sales by Country (K Dose), 2021–2026
Table 27. North America Human Insulin Injections Sales by Country (K Dose), 2027–2032
Table 28. North America Human Insulin Injections Revenue by Country (US$ Million), 2021–2026
Table 29. North America Human Insulin Injections Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Human Insulin Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Human Insulin Injections Sales by Country (K Dose), 2021–2026
Table 32. Europe Human Insulin Injections Sales by Country (K Dose), 2027–2032
Table 33. Europe Human Insulin Injections Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Human Insulin Injections Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Human Insulin Injections Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Human Insulin Injections Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Human Insulin Injections Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Human Insulin Injections Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Human Insulin Injections Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Human Insulin Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Human Insulin Injections Sales by Country (K Dose), 2021–2026
Table 42. Latin America Human Insulin Injections Sales by Country (K Dose), 2027–2032
Table 43. Latin America Human Insulin Injections Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Human Insulin Injections Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Human Insulin Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Human Insulin Injections Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Human Insulin Injections Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Human Insulin Injections Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Human Insulin Injections Revenue by Country (US$ Million), 2027–2032
Table 50. Global Human Insulin Injections Sales (K Dose) by Type (2021–2026)
Table 51. Global Human Insulin Injections Sales (K Dose) by Type (2027–2032)
Table 52. Global Human Insulin Injections Sales Market Share by Type (2021–2026)
Table 53. Global Human Insulin Injections Sales Market Share by Type (2027–2032)
Table 54. Global Human Insulin Injections Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Human Insulin Injections Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Human Insulin Injections Revenue Market Share by Type (2021–2026)
Table 57. Global Human Insulin Injections Revenue Market Share by Type (2027–2032)
Table 58. Global Human Insulin Injections Price (US$/Dose) by Type (2021–2026)
Table 59. Global Human Insulin Injections Price (US$/Dose) by Type (2027–2032)
Table 60. Global Human Insulin Injections Sales (K Dose) by Application (2021–2026)
Table 61. Global Human Insulin Injections Sales (K Dose) by Application (2027–2032)
Table 62. Global Human Insulin Injections Sales Market Share by Application (2021–2026)
Table 63. Global Human Insulin Injections Sales Market Share by Application (2027–2032)
Table 64. Global Human Insulin Injections Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Human Insulin Injections Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Human Insulin Injections Revenue Market Share by Application (2021–2026)
Table 67. Global Human Insulin Injections Revenue Market Share by Application (2027–2032)
Table 68. Global Human Insulin Injections Price (US$/Dose) by Application (2021–2026)
Table 69. Global Human Insulin Injections Price (US$/Dose) by Application (2027–2032)
Table 70. BIOTON S.A. Company Information
Table 71. BIOTON S.A. Description and Business Overview
Table 72. BIOTON S.A. Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. BIOTON S.A. Human Insulin Injections Product
Table 74. BIOTON S.A. Recent Developments/Updates
Table 75. Lilly France Company Information
Table 76. Lilly France Description and Business Overview
Table 77. Lilly France Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Lilly France Human Insulin Injections Product
Table 79. Lilly France Recent Developments/Updates
Table 80. Novo Nordisk Company Information
Table 81. Novo Nordisk Description and Business Overview
Table 82. Novo Nordisk Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Novo Nordisk Human Insulin Injections Product
Table 84. Novo Nordisk Recent Developments/Updates
Table 85. Eli Lilly Company Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Eli Lilly Human Insulin Injections Product
Table 89. Eli Lilly Recent Developments/Updates
Table 90. Sanofi-Aventis Company Information
Table 91. Sanofi-Aventis Description and Business Overview
Table 92. Sanofi-Aventis Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Sanofi-Aventis Human Insulin Injections Product
Table 94. Sanofi-Aventis Recent Developments/Updates
Table 95. Tonghua Dongbao Company Information
Table 96. Tonghua Dongbao Description and Business Overview
Table 97. Tonghua Dongbao Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Tonghua Dongbao Human Insulin Injections Product
Table 99. Tonghua Dongbao Recent Developments/Updates
Table 100. Ganlee Company Information
Table 101. Ganlee Description and Business Overview
Table 102. Ganlee Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Ganlee Human Insulin Injections Product
Table 104. Ganlee Recent Developments/Updates
Table 105. United Laboratory Company Information
Table 106. United Laboratory Description and Business Overview
Table 107. United Laboratory Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. United Laboratory Human Insulin Injections Product
Table 109. United Laboratory Recent Developments/Updates
Table 110. Jiangsu Wanbang Company Information
Table 111. Jiangsu Wanbang Description and Business Overview
Table 112. Jiangsu Wanbang Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. Jiangsu Wanbang Human Insulin Injections Product
Table 114. Jiangsu Wanbang Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Human Insulin Injections Distributors List
Table 118. Human Insulin Injections Customers List
Table 119. Human Insulin Injections Market Trends
Table 120. Human Insulin Injections Market Drivers
Table 121. Human Insulin Injections Market Challenges
Table 122. Human Insulin Injections Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Insulin Injections
Figure 2. Global Human Insulin Injections Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Human Insulin Injections Market Share by Type: 2025 & 2032
Figure 4. 3ml Product Picture
Figure 5. 10ml Product Picture
Figure 6. Global Human Insulin Injections Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Human Insulin Injections Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Human Insulin Injections Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Human Insulin Injections Market Size (US$ Million), 2021–2032
Figure 13. Global Human Insulin Injections Sales (K Dose), 2021–2032
Figure 14. Global Human Insulin Injections Average Price (US$/Dose), 2021–2032
Figure 15. Human Insulin Injections Report Years Considered
Figure 16. Human Insulin Injections Sales Share by Manufacturers in 2025
Figure 17. Global Human Insulin Injections Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Human Insulin Injections Players: Market Share by Revenue in Human Insulin Injections in 2025
Figure 19. Human Insulin Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Human Insulin Injections Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Human Insulin Injections Sales Market Share by Country (2021–2032)
Figure 22. North America Human Insulin Injections Revenue Market Share by Country (2021–2032)
Figure 23. United States Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Human Insulin Injections Sales Market Share by Country (2021–2032)
Figure 26. Europe Human Insulin Injections Revenue Market Share by Country (2021–2032)
Figure 27. Germany Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Human Insulin Injections Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Human Insulin Injections Revenue Market Share by Region (2021–2032)
Figure 34. China Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Human Insulin Injections Sales Market Share by Country (2021–2032)
Figure 42. Latin America Human Insulin Injections Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Human Insulin Injections Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Human Insulin Injections Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Human Insulin Injections by Type (2021–2032)
Figure 53. Global Revenue Market Share of Human Insulin Injections by Type (2021–2032)
Figure 54. Global Human Insulin Injections Price (US$/Dose) by Type (2021–2032)
Figure 55. Global Sales Market Share of Human Insulin Injections by Application (2021–2032)
Figure 56. Global Revenue Market Share of Human Insulin Injections by Application (2021–2032)
Figure 57. Global Human Insulin Injections Price (US$/Dose) by Application (2021–2032)
Figure 58. Human Insulin Injections Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
